To the Editor—We thank Dr Rezahosseini for his valuable comments [1] on our study. We agree that multiple measures must be undertaken to increase the robustness of results in observational studies and that the results need to be interpreted carefully.
The combination of diagnoses used to define acute liver injury in our study has been previously evaluated in different settings with reported positive predictive values ranging from 75% to 95% [2, 3]. Furthermore, we excluded patients who were hospitalized for any other diagnoses, which in this case would include patients admitted for sepsis. We do agree with the author’s comment that the fluoroquinolones are more often used in gram-negative infections as compared to amoxicillin and that the lack of indication of treatment is a weakness, as described in the article. However, since we excluded any treatment episodes that were preceded by hospitalization in the past 2 months, we find it unlikely that the choice of antibiotic in an outpatient setting is based on a specific pathogen (ie, gram negative or gram positive) rather than a presumed site of infection for which there are overlapping areas between the compared antibiotics. Furthermore, biochemical markers of liver insults, such as increased values of aminotransferases, bilirubin, and international normalized ratio, are sometimes seen in septic patients (without regard of causative organism). However, in a large epidemiologic study from 2017 looking at patients with severe sepsis according to Sepsis-2, only 2151 of 197724 (1.1%) patients had a hepatic Sequential Organ Failure Assessment score ≥2, making it a rare occurrence [4].
Notes
Disclaimer. The funders played no role in the design of the study, data collection or analysis, decision to publish, or preparation of the manuscript. Funding was paid to their institution.
Financial support. M. I. reports the following support: Swedish Government Funds for Clinical Research (ALF), Scandinavian Society for Antimicrobial Chemotherapy Foundation, and Royal Physiographic Society in Lund. O. N. reports support from Elsa Lundberg and Greta Fleron, paid to their institution.
Potential conflicts of interest. The authors: No reported conflicts of interest. Both authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest.
Contributor Information
Olof Nibell, Section for Infection Medicine, Department of Clinical Sciences Lund, Lund University, Lund, Sweden.
Malin Inghammar, Section for Infection Medicine, Department of Clinical Sciences Lund, Lund University, Lund, Sweden.
References
- 1. Rezahosseini O. Oral fluoroquinolone and the risk of acute liver injury: is it related to the antibiotics or the infection? Clin Infect Dis 2022;74:2261. [DOI] [PubMed] [Google Scholar]
- 2. Forns J, Cainzos-Achirica M, Hellfritzsch M, et al. Validity of ICD-9 and ICD-10 codes used to identify acute liver injury: a study in three European data sources. Pharmacoepidemiol Drug Saf 2019; 28:965–75. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3. Myers RP, Leung Y, Shaheen AA, Li B.. Validation of ICD-9-CM/ICD-10 coding algorithms for the identification of patients with acetaminophen overdose and hepatotoxicity using administrative data. BMC Health Serv Res 2007; 7:159. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4. Shankar-Hari M, Harrison DA, Rubenfeld GD, Rowan K.. Epidemiology of sepsis and septic shock in critical care units: comparison between Sepsis-2 and Sepsis-3 populations using a national critical care database. Br J Anaesth 2017; 119:626–36. [DOI] [PubMed] [Google Scholar]